Addex Therapeutics Ltd Financial Flexibility Index
Addex Therapeutics Ltd financial flexibility index. Addex Therapeutics Ltd (ADXN) has a Financial Flexibility Index of -0.52x as of March 2026. Free cash flow of $-765.84K (operating CF $-765.84K minus capex $0.00) represents -1% of total liabilities ($1.47 Million). See Addex Therapeutics Ltd free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Addex Therapeutics Ltd (2006–2025)
Financial flexibility index of Addex Therapeutics Ltd from 2006 to 2025. Historical Financial Flexibility Index trend for Addex Therapeutics Ltd across 20 annual periods. Check ADXN cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
Addex Therapeutics Ltd Financial Flexibility Index by Year (2006–2025)
Addex Therapeutics Ltd financial flexibility index by year from 2006 to 2025. Year-by-year free cash flow to debt coverage for Addex Therapeutics Ltd. For the full cash flow conversion analysis, see Addex Therapeutics Ltd (ADXN) cash conversion ratio.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -1.30x | $-2.08 Million | $-2.08 Million | $1.60 Million | ▲ +75.8% |
| 2024 | -5.37x | $-5.37 Million | $-5.37 Million | $1.00 Million | ▼ -135.0% |
| 2023 | -2.28x | $-7.99 Million | $-7.99 Million | $3.50 Million | ▲ +53.2% |
| 2022 | -4.88x | $-16.44 Million | $-16.44 Million | $3.37 Million | ▼ -86.5% |
| 2021 | -2.62x | $-14.67 Million | $-14.71 Million | $5.61 Million | ▼ -20.2% |
| 2020 | -2.18x | $-12.12 Million | $-12.18 Million | $5.57 Million | ▼ -72.7% |
| 2019 | -1.26x | $-9.45 Million | $-9.48 Million | $7.50 Million | ▼ -312.7% |
| 2018 | 0.59x | $1.76 Million | $1.75 Million | $2.97 Million | ▲ +147.7% |
| 2017 | -1.24x | $-2.13 Million | $-2.13 Million | $1.72 Million | ▲ +32.3% |
| 2016 | -1.83x | $-2.68 Million | $-2.69 Million | $1.46 Million | ▲ +14.2% |
| 2015 | -2.14x | $-2.62 Million | $-2.63 Million | $1.23 Million | ▼ -96.2% |
| 2014 | -1.09x | $-1.80 Million | $-1.80 Million | $1.65 Million | ▲ +80.3% |
| 2013 | -5.53x | $-15.78 Million | $-15.78 Million | $2.85 Million | ▼ -3.4% |
| 2012 | -5.35x | $-29.12 Million | $-29.45 Million | $5.44 Million | ▼ -98.5% |
| 2011 | -2.69x | $-26.35 Million | $-26.55 Million | $9.78 Million | ▲ +13.9% |
| 2010 | -3.13x | $-30.89 Million | $-31.34 Million | $9.87 Million | ▲ +2.4% |
| 2009 | -3.20x | $-35.17 Million | $-39.38 Million | $10.97 Million | ▼ -250.9% |
| 2008 | -0.91x | $-12.18 Million | $-17.79 Million | $13.34 Million | ▲ +72.0% |
| 2007 | -3.27x | $-30.28 Million | $-33.00 Million | $9.27 Million | ▲ +30.7% |
| 2006 | -4.71x | $-19.20 Million | $-19.56 Million | $4.07 Million | — |